The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 Dendreon Corp  (DNDN) Trade Now »     Rate DNDN  -  Discuss DNDN  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
SocialPicks Sentiment:

** v.s. other stocks 		This Quarter's Sentiment:
All:
76.0%
Top:
75.0%
Rate DNDN:


Home
Analysis & Videos
Quotes
Bull or Bear
Discuss
        

DNDN: Bull or Bear? From:    SocialPicks  |  Blogsphere  |  All

SocialPicks Community

Bullish on DNDN ... Graphic_rating_buy DNDN
Foto
62%
Dendreon Corporation, a biotechnology company, engages in the discovery, development, and commercialization of therapeutics to improve cancer treatment options for patients. The companyÂ’s product portfolio includes active cellular immunotherapy, monoclonal antibody, and small molecule product candidates to treat various cancers. Its product candidates include Provenge, an active cellular immunotherapy that has completed two phase 3 trials for the treatment of asymptomatic, metastatic, and androgen-independent prostate cancer; and Neuvenge (lapuleucel-T), an investigational active immunothe...
By  Marian Filo   (-24.55%  risk: aggressive)  04/06/09 Comment


FDA Calendar Updates: SNTS, CEPH, AZN, DNDN, GILD, NVO Graphic_rating_buy DNDN
Mikerun
73%
Below is a summary of updates to the BioMedReports.com database of 239 entries included in the FDA and Clinical Trial Calendars . You can also follow me on Twitter at http://twitter.com/mikehavrilla
 
<> The FDA Calendar includes companies with pending new drug, biological agent, or medical device new product decisions at the FDA sorted by their PDUFA deadline dates. The entries are updated on a daily basis as new information becomes available with a total of 112 entries through 4/6/09. The FDA Calendar includes the following information: company name, ticker...
By  Mike Havrilla   (+1.04%  risk: conservative)  04/06/09 Comment


Calendar of 163 FDA Decisions and Clinical Trials Graphic_rating_buy DNDN
Mikerun
73%
The tables at my web link below include an updated calendar of 80 expected FDA new product decisions and 83 pending clinical trial result estimates + pending FDA re-submissions. Click here for a link to my previous FDA calendars and the below is a summary of new entries and updates on the calendars.
 
 
<> 1.) Genentech (DNA) expects to report results in mid-April in its Avastin colon cancer adjuvant trial, in addition to pending FDA decisions to expand product labels for Avastin in relaps...
By  Mike Havrilla   (+1.04%  risk: conservative)  01/21/09 Comment


Dendreon Corp Graphic_rating_buy DNDN
83%
Dendreon Corp will be presenting at The JP Morgan Healthcare Conference on January 15, 2008. We believe the company will be releasing some news that will be very favorable for those long the stock.
By  navivest   (+101.81%  risk: conservative)  01/14/09 Comment


UpDown Virtual Investing: Earn Real Money with Zero Risk Graphic_rating_buy DNDN
Mikerun
73%

UpDown Virtual Investing: Earn Real Money with Zero Risk

<>

Start earning real money with zero risk while improving your trading skills and strategies at the UpDown Virtual Investing website -- just click on the image above or any of the text links to the site in this article to sign up today. My stats and profile are featured in the accompanying table and on my blog site below the last posted entry. I started trading at the UpDown on 11/23/08 with a gain of about 29% through today -- my profile name on the site is 'ETFinnovators' with a portfolio of long...
By  Mike Havrilla   (+1.04%  risk: conservative)  12/28/08 1 comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.25% 381
2 Gerald Greene 18.14 +72.34% 210
3 stockmarketfunding.com 17.66 +25.65% 55
4 akiralegrand 13.47 +14.32% 61
5 anup2104 12.13 +76.91% 39


POPULAR STOCKS
Symbol Company Name Sentiment
SBUX Starbucks Corp
YHOO Yahoo! Inc
F Ford Motor Company
AMD Advanced Micro Devices Inc
RIMM Research in Motion Ltd
MCD McDonald's Corp.

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on DNDN

Visit streetinsider.com


Discussion Wall + Add  
tanumoy   (+110.44%  risk: conservative)
Upcoming data of an Alzheimer's drug to be presente.. - A small cap company is going to be presenting data on their Alzheimer's drug at the Alzheimer's conference in July. If the trials data is positive, it...
+   0 replies


More Resources

Graphic_arrow1 About Dendreon Corp - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch